Sergio Teixeira Ferreira

This study develops a next-generation AAV vector expressing optimized XBP1s to improve proteostasis, reducing Alzheimer's disease features in mouse models.

This study shows that reducing FMRP and 4E-BP2 in mice prevents memory loss caused by Alzheimer's disease-linked amyloid-beta oligomers.

This study shows that LASSBio-1911, an iHDAC6 inhibitor, improves cognitive function and astrocyte function in AβO-infused mice.

The paper investigates how maternal physical exercise during pregnancy affects ADHD-like behaviors and dopamine receptor expression in offspring rats.

This study shows that AAV-delivered scFv antibodies targeting Aβ oligomers protect synapses and rescue memory in Alzheimer's disease models.

This study shows that oxytocin reduces microglial activation and improves memory in Alzheimer's disease mouse models.

This study shows that reduced lipoxin A4 levels in aging brains contribute to cognitive deficits in mice and humans, suggesting LXA4 as a potential therapeutic target for age-related dementia.

This study shows that reducing eIF2-P in Alzheimer's mouse models improves protein synthesis, synaptic plasticity, and memory.

This study investigates long-term effects of neonatal ZIKV infection in mice, finding persistent viral replication, brain damage, and behavioral issues despite initial recovery.